What Should Investors Know About Bed Bath & Beyond (BBBY) Stock?

By Tamara Parker • Thursday, March 30 12:40 • Permanent Link

One of the losers of today's trading session was Bed Bath & Beyond. Shares of the retail company plunged -22.8%, and some investors may be wondering if its price of $0.62 would make a good entry point. Here's what you should know if you are considering this investment:

Bed Bath & Beyond has moved -96.4% over the last year
BBBY has an average analyst rating of underperform and is -61.64% away from its mean target price of $1.62 per share
Its trailing earnings per share (EPS) is $-15.21
Its forward earnings per share (EPS) is $-5.91 and its forward P/E ratio is -0.1
The company has a free cash flow of $-552,069,312.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products. The company operates stores under the name Bed Bath & Beyond, buybuy BABY, Harmon, Harmon Face Values or Face Values. It also offers products through various Websites and applications comprising bedbathandbeyond.com, bedbathandbeyond.ca, harmondiscount.com, facevalues.com, buybuybaby.com, buybuybaby.ca, and decorist.com. In addition, the company operates Decorist, an online interior design platform that provides personalized home design services. Bed Bath & Beyond Inc. was incorporated in 1971 and is headquartered in Union, New Jersey.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.